The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Pfizer; Sanofi
Research Funding - Bayer (Inst)
Phase 2 study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients (pts) with progressive metastatic castrate-resistant prostate cancer (mCRPC).
 
Teresa Alonso Gordoa
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Lilly; Merck; Pfizer; Roche; Sanofi
Research Funding - Ipsen; Pfizer; Roche
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Michael Moses Goodman
Consulting or Advisory Role - Alexion Pharmaceuticals; Sanofi/Aventis
Research Funding - AstraZeneca (Inst); Genentech (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genentech
 
Christof Vulsteke
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Atheneum; Bayer; Bristol-Myers Squibb/Pfizer; GlaxoSmithKline; Janssen; LEO Pharma; MSD; Roche/Genentech
Research Funding - LEO Pharma (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Roche
 
Guilhem Roubaud
No Relationships to Disclose
 
Jingsong Zhang
Honoraria - AstraZeneca/MedImmune; Bayer; Dendreon; EMD Serono; Pfizer; Sanofi; Sanofi/Aventis; Seagen
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Dendreon; EMD Serono; Pfizer
Speakers' Bureau - AstraZeneca; Dendreon; Sanofi; Seagen
 
Mamta Parikh
Consulting or Advisory Role - AstraZeneca; Exelixis; OncoCyte; Seagen
Research Funding - Karyopharm Therapeutics
 
Josep M. Piulats
Consulting or Advisory Role - Astellas Pharma; BeiGene; Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; Merck Sharp & Dohme; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Incyte; Janssen Oncology; Merck Sharp & Dohme; Pfizer/EMD Serono
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; Roche
 
Analía Azaro
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Gareth D James
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); UCB (Inst)
 
Riccardo Cavazzina
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Eric Gangl
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Jeff Thompson
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Gayle Pageau Pouliot
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Rakesh Kumar
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Christopher Sweeney
Stock and Other Ownership Interests - Leuchemix
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Genentech/Roche; Janssen Biotech; Lilly; Pfizer; POINT Biopharma; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon; Janssen Biotech (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination